Trial intelligence / Profile preview

D-FREE dasatinib treatment-free remission study in chronic-phase CML

jRCTs031180332Phase 2Completed

Sponsor

Bristol Myers Squibb

Start

Jun 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1